Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Supply Belgium's First Psilocybin Compassionate Use Program, to Help Open the Door to Patient Access for Treatment-Resistant Depression @redlighttrip #Cannabis #Marijuana #MarijuanaStocks #PotStocks #CSEStocks #OTC #OTCMarkets #OTCStocks #SmallCaps #Investing
Filament has signed an agreement to supply PEX010 to Epsylon ASBL for what the Company believes will be the first program in Belgium to give patients access to psilocybin outside a clinical trial.Filament will offer regulatory support and update on the program's progress towards regulatory approval.Toronto, Ontario--(Newsfile Corp. - October 16, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing...
http://dlvr.it/TVxXXy
http://dlvr.it/TVxXXy
Comments
Post a Comment